Tuesday, November 07, 2006 5:48:00 PM
"Geez, are we starting this conversation over again?
Originally, the JDA awarded 35% "bid interest" to Noble/ERHE; ERHE 25% "signature free"; Conoil 20%; Hercules 10% Godsonic 5%; Overt 5%.
At some point in time the JDA allowed Noble to drop out of the 35% Noble/ERHE bid award and allowed the replacement of Addax/ERHE BUT lowered the bid interest to 26%. The 9% additional bid interest was given to Godsonic (who already had 5%) from the JDA as part of the final award process. NO Compensation to ERHE or SEC filing required by ERHE was or is necessary as the 9% interest was not ERHE's to begin with or to negotiate away. Granted, it was not very clear how/why/when Godsonic obtained the additional 9% award but I have a guess that Addax originally was not interested in covering 60% of the expense for drilling in block 4 OR Godsonic somehow negotiated to allow Addax to replace Noble as long as they got 9% more.
Therefore, ERHE always retained its 25% signature free award. It then negotiated part of it's 25% signature free portion to Addax for the upfront expense free ride to oil production. ERHE ended up with 17.7% signature and upfront-expense free ride (paid for by Addax and ultimately recovered from oil production). Addax then had 33.3% (33.3 + 17.7 = 51% block 4 award).
On April 13th, Addax acquired and PR'ed the addition of 5% interest in Block 4 from Overt Ventures.
Current Breakdown of Block 4 Award:
Addax now has 38.3%
ERHE 17.7%
Conoil 20%
Godsonic 14%
Hercules 10%
TOTAL 100% End of current discussion until changes are made."
Good luck all,
Strategyone
Recent ERHE News
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/06/2024 07:31:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2023 09:06:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 05:35:35 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM